Disc Medicine, Inc. (IRON)
67.04
+2.97
(+4.64%)
USD |
NASDAQ |
May 20, 16:00
67.04
0.00 (0.00%)
After-Hours: 20:00
Disc Medicine Shareholders Equity (Quarterly) : 688.43M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Cytokinetics, Inc. | -826.57M |
| Regeneron Pharmaceuticals, Inc. | 31.42B |
| REGENXBIO, Inc. | 21.08M |
| Replimune Group, Inc. | 210.54M |
| Olema Pharmaceuticals, Inc. | 480.48M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 750.21M |
| Total Liabilities (Quarterly) | 61.78M |
| Debt to Equity Ratio | 0.0451 |
| Current Ratio | 24.00 |
| Net Debt Paydown Yield | -0.01% |